Comparative Study between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients
Type 2 diabetes mellitus is often characterized by hyperglycemia as a result of increased insulin resistance in hepatic/peripheral tissues and pancreactic B-cell dysfunction. Approximately 92% of patients with type 2 diabetes mellitus demonstrate insulin resistance, however hyperglycemia is always...
Main Authors: | Sardar Kader, Kassim J.Al-Shamma, Ibrahim A. Majeed, Abdulla T. Al-Ani |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy University of Baghdad
2017-03-01
|
Series: | Iraqi Journal of Pharmaceutical Sciences |
Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/530 |
Similar Items
-
Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats
by: Bonaventure Chukwunonso Obi, et al.
Published: (2016-01-01) -
Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients
by: Hassan M. Al-Temimi, et al.
Published: (2017-03-01) -
Vortex assisted liquid-liquid microextraction with back extraction of repaglinide, glibenclamide and glimepiride in water samples
by: Sohaib Jumaah Owaid Luhaib, et al.
Published: (2021) -
Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model
by: Marianne Berdugo, et al.
Published: (2021-07-01) -
Determination of glibenclamide, metformin hydrochloride and rosiglitazone maleate by reversed phase liquid chromatographic technique in tablet dosage form
by: Havele Shweta S., et al.
Published: (2014-01-01)